?? Acadia Pharmaceuticals Inc. & Vanderbilt’s WCNDD have been teaming up to develop novel drugs targeting the muscarinic M1 receptor to treat CNS disorders. This cutting-edge research could improve cognitive function & mental health! ???? #neuroscience #discovery #science #chemistry #neuro #cns #cnsdisease #cnsdisorders #partnerships
